|
2022
|
Invention
|
Orodispersible formulation of hypolipidemic agent. Present invention relates to orodispersible fo... |
|
|
Invention
|
Parenteral compositions comprising methylene blue.
The present invention relates to parenteral c... |
|
|
Invention
|
Enantiomerically pure desglymidodrine and process for preparation thereof. The invention relates ... |
|
2021
|
Invention
|
Novel compounds suitable for the treatment of dyslipidemia. Present invention relates to compound... |
|
|
Invention
|
Novel inhibitors of autotaxin.
The present invention relates to compounds of the general formula... |
|
|
Invention
|
Novel inhibitors of autotaxin. The present invention relates to compounds of the general formula ... |
|
|
Invention
|
Anti-sars-cov-2 monoclonal antibodies and cocktail thereof. The present invention provides monocl... |
|
|
Invention
|
Novel hetrocyclic compounds. The present invention relates to novel compounds of general formula ... |
|
|
Invention
|
Parenteral solutions of selective cyclooxygenase-2 (cox-2) inhibitor and use therof for treating ... |
|
|
Invention
|
Novel amide derivatives. The present invention relates to novel compounds of the general formula ... |
|
|
Invention
|
Inhibitors of low molecular weight protein tyrosine phosphatase for management of metabolic disor... |
|
|
Invention
|
Novel inhibitors of autotaxin. The present invention relates to novel heterocyclic compounds of g... |
|
|
Invention
|
Preparation of metformin hydrochloride free from genotoxic impurity.
A high purity metformin hyd... |
|
|
Invention
|
A composition of pegylated interferon alpha-2b for the treatment of sars-cov-2 infection and rela... |
|
|
Invention
|
Treatment for the inflammatory bowel disease. Present invention relates to development of compoun... |
|
|
Invention
|
Treatment for psoriasis and skin inflammatory diseases. Present invention relates to development ... |
|
|
Invention
|
Fc variant and preparation thereof. The present invention relates to Fc variant protein and prepa... |
|
|
Invention
|
Stable aqueous parenteral solutions of nonsteroidal anti-inflammatory drug (nsaid). The present i... |
|
|
Invention
|
Pharmaceutical compositions for combination therapy. Present invention describes synergistic comp... |
|
|
Invention
|
A vaccine against sars-cov-2 and preparation thereof. The current invention provides a DNA constr... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertrigly... |
|
|
Invention
|
Stable aqueous parenteral solutions of desglymidodrine. The present invention relates to stable a... |
|
|
Invention
|
Formulation comprising hif prolyl hydroxylase inhibitors. The present invention generally relates... |
|
|
Invention
|
Novel salts of quinolone compounds. The present invention relates to novel pharmaceutically accep... |
|
|
Invention
|
Novel substituted sulfonylurea and sulfoximineurea derivatives. The present invention relates to ... |
|
|
Invention
|
Pharmaceutical compositions of sitagliptin.
The present invention relates to stable oral pharmac... |
|
|
Invention
|
Process for preparation of fosnetupitant.
The present invention relates to a process for the pre... |
|
|
Invention
|
Anti-properdin antibodies and preparation thereof. γγRs to minimize its ADCC activity. The presen... |
|
2020
|
Invention
|
Novel compounds suitable for the treatment of dyslipidemia. The present invention relates to comp... |
|
|
Invention
|
Modified release pharmaceutical compositions of riociguat. The present invention relates to modif... |
|
|
Invention
|
Pharmaceutical formulation of anti-her2 antibody and preparation thereof. The present invention p... |
|
|
Invention
|
Intranasal pharmaceutical compositions of cyclobenzaprine.
The present invention relates to intr... |
|
|
Invention
|
Intranasal pharmaceutical compositions of cyclobenzaprine. The present invention relates to intra... |
|
|
Invention
|
Stable aqueous parenteral solutions of nonsteroidal anti-inflammatory drugs (nsaids).
The invent... |
|
|
Invention
|
Stable aqueous parenteral solutions of nonsteroidal anti-inflammatory drugs (nsaids). The inventi... |
|
|
Invention
|
Novel substituted sulfoximine derivatives.
The present invention relates to novel heterocyclic c... |
|
|
Invention
|
Novel substituted sulfoximine derivatives. The present invention relates to novel heterocyclic co... |
|
|
Invention
|
Antibodies to human programmed death receptor pd-1.
The present invention relates to an antibody... |
|
|
Invention
|
Antibodies to human programmed death receptor pd-1. The present invention relates to an antibody ... |
|
|
Invention
|
Angptl3 based vaccine for the treatment of liver disease.
The present invention relates to a vac... |
|
|
Invention
|
Angptl3 based vaccine for the treatment of liver disease. in vivoin vivo. More specifically, the ... |
|
|
Invention
|
Treatment for primary biliary cholangitis.
The present invention provides therapeutic compound f... |
|
|
Invention
|
Amorphous ertugliflozin and process for its preparation.
An amorphous form of ertugliflozin and ... |
|
|
Invention
|
Novel salts, crystalline forms and premix of hypolipidemic agent. Present invention relates to no... |
|
|
Invention
|
Treatment for polycystic ovarian syndrome (pcos). Present invention provides the method of treati... |
|
2019
|
Invention
|
Novel compounds for the treatment of mammalian infections. Present invention relates to the novel... |
|
|
Invention
|
Condensed azaheteroaryl compounds having antibacterial activity against tuberculosis bacteria.
P... |
|
|
Invention
|
Heterocyclic compounds useful as antibacterial agents.
Present invention relates to compounds of... |
|
2018
|
Invention
|
Novel protein drug conjugate formulation.
The invention provides stable pharmaceutical formulati... |
|
2017
|
G/S
|
Medicinal and pharmaceutical preparations. |
|
2015
|
G/S
|
Preparation of adalimumab in various dosage forms either as
single ingredient or in combinations... |
|
2013
|
G/S
|
Medicinal and pharmaceuticals preparations. |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, non-alcoholic ste... |
